After adjusting for the effects of age and body mass index (BMI), significantly lower serum irisin levels were also found significantly lower in breast cancer female patients with spinal metastasis compared to those without spinal metastasis, suggesting a protective role of irisin on spinal metastasis in breast cancer patients [92]. Here, FNDC5 is linked to breast carcinoma.